Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk of Polymyxin B-induced Acute Kidney Injury in Non-adjusted Dose Versus Adjusted Dose based on Renal Function: a retrospective cohort study

Guanhao Zheng, Shenghui Zhou, Ning Du, Jiaqi Cai, Hao Bai, Juan He, Xiaolan Bian
doi: https://doi.org/10.1101/2020.11.23.20237479
Guanhao Zheng
1Department of Pharmacy, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ken_zheng@foxmail.com
Shenghui Zhou
2Department of Pharmacy, Baiyin Central Hospital, Baiyin, Gansu, China,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 18295289387@163.com
Ning Du
3Department of Pharmacy, Qiqihar First Hospital, Qiqihar, Heilongjiang, China,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 313732801@qq.com
Jiaqi Cai
4Department of clinical laboratory, Kunshan Hospital Affiliated to Nanjing University of Chinese Medicine, Kunshan, Jiangsu, China,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: caijiaqi99@sina.com
Hao Bai
5Department of pharmacy, Chongqing University Cancer Hospital, Chongqing, China,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 474027594@qq.com
Juan He
6Department of Pharmacy, Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, China,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hejuanwin@126.com hejuanwin@126.com
Xiaolan Bian
7Department of Pharmacy, Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, China,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bxl70029@163.com bxl70029@163.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background This study aimed to observe the difference in risk of polymyxin B-induced acute kidney injury with or without dose adjustment by patients’ renal function.

Method A retrospective cohort analysis was carried out for patients who were treated with polymyxin B in Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine from November 2018 to October 2019. Patients were divided into adjusted dosage group and non-adjusted dosage group depended on dosage adjustment with renal function or not. A comparison of acute kidney injury incidence between the two groups was the primary outcome of this research. The secondary outcome included hospital length of stay, microbiological cure, clinical cure, and 30-day mortality.

Result A total of 115 patients met the requirements of this study and were included in the analysis. Thirty-five patients were included in the non-adjusted dosage group and 80 in the adjusted dosage group. Patients from both groups had similar characteristics. The total daily dose of polymyxin B in the Non-adjusted dosage group was significantly higher than the adjusted dosage group (1.98 mg/kg/d vs 1.59 mg/kg/d, P=0.001). For the primary outcome of this research, no significant difference in the incidence of acute kidney injury was observed in these two groups (47.5% vs 37.14%, P=0.304), as well as the secondary outcomes, including hospital length of stay, microbiological cure, clinical cure, 30-day mortality.

Conclusion Dosing adjustment renally could not lower the risk of polymyxin B-induced acute kidney injury significantly. A non-adjusted dosing strategy of polymyxin B is recommended when patients suffered from various levels of renal impairment.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors received no specific funding for this paper.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by Ruijin Hospital Institutional Review Board and has been performed in accordance with the ethical standards laid down in Declaration of Helsinki 1964 and its later amendments or comparable ethical standards.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data and material used and/or analyzed during the current study are available from the corresponding author on reasonable request.

  • Abbreviations

    PMB
    polymyxin B
    MDR
    multiple drug resistant
    AKI
    acute kidney injury
    PK/PD
    pharmacokinetic/pharmacodynamic
    CrCl
    creatinine clearance
    sCr
    serum creatinine
    LOS
    length of stay
    APACHE II
    Acute Physiology and Chronic Health Evaluation II
    CRE
    Carbapenem-Resistant Enterobacteriaceae
    RCT
    Randomized Controlled Trial
    TDM
    therapeutic drug monitoring.
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted November 24, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Risk of Polymyxin B-induced Acute Kidney Injury in Non-adjusted Dose Versus Adjusted Dose based on Renal Function: a retrospective cohort study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Risk of Polymyxin B-induced Acute Kidney Injury in Non-adjusted Dose Versus Adjusted Dose based on Renal Function: a retrospective cohort study
    Guanhao Zheng, Shenghui Zhou, Ning Du, Jiaqi Cai, Hao Bai, Juan He, Xiaolan Bian
    medRxiv 2020.11.23.20237479; doi: https://doi.org/10.1101/2020.11.23.20237479
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Risk of Polymyxin B-induced Acute Kidney Injury in Non-adjusted Dose Versus Adjusted Dose based on Renal Function: a retrospective cohort study
    Guanhao Zheng, Shenghui Zhou, Ning Du, Jiaqi Cai, Hao Bai, Juan He, Xiaolan Bian
    medRxiv 2020.11.23.20237479; doi: https://doi.org/10.1101/2020.11.23.20237479

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Nephrology
    Subject Areas
    All Articles
    • Addiction Medicine (62)
    • Allergy and Immunology (144)
    • Anesthesia (47)
    • Cardiovascular Medicine (419)
    • Dentistry and Oral Medicine (72)
    • Dermatology (49)
    • Emergency Medicine (147)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (174)
    • Epidemiology (4906)
    • Forensic Medicine (3)
    • Gastroenterology (185)
    • Genetic and Genomic Medicine (689)
    • Geriatric Medicine (72)
    • Health Economics (193)
    • Health Informatics (636)
    • Health Policy (322)
    • Health Systems and Quality Improvement (209)
    • Hematology (86)
    • HIV/AIDS (157)
    • Infectious Diseases (except HIV/AIDS) (5408)
    • Intensive Care and Critical Care Medicine (333)
    • Medical Education (96)
    • Medical Ethics (24)
    • Nephrology (77)
    • Neurology (692)
    • Nursing (42)
    • Nutrition (115)
    • Obstetrics and Gynecology (128)
    • Occupational and Environmental Health (211)
    • Oncology (447)
    • Ophthalmology (140)
    • Orthopedics (36)
    • Otolaryngology (91)
    • Pain Medicine (37)
    • Palliative Medicine (18)
    • Pathology (131)
    • Pediatrics (201)
    • Pharmacology and Therapeutics (131)
    • Primary Care Research (88)
    • Psychiatry and Clinical Psychology (787)
    • Public and Global Health (1832)
    • Radiology and Imaging (328)
    • Rehabilitation Medicine and Physical Therapy (142)
    • Respiratory Medicine (257)
    • Rheumatology (87)
    • Sexual and Reproductive Health (69)
    • Sports Medicine (63)
    • Surgery (102)
    • Toxicology (23)
    • Transplantation (29)
    • Urology (38)